BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33371312)

  • 21. Platelets in vascular disease.
    Reinhart WH
    Clin Hemorheol Microcirc; 2013; 53(1-2):71-9. PubMed ID: 22954635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the platelet releasate.
    Coppinger JA; Maguire PB
    Curr Pharm Des; 2007; 13(26):2640-6. PubMed ID: 17897006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-leukocyte interplay during vascular disease.
    Schrottmaier WC; Mussbacher M; Salzmann M; Assinger A
    Atherosclerosis; 2020 Aug; 307():109-120. PubMed ID: 32439204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelets in atherosclerosis and thrombosis.
    Schulz C; Massberg S
    Handb Exp Pharmacol; 2012; (210):111-33. PubMed ID: 22918729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complexity of platelet metabolism and its contribution to atherothrombosis.
    Puddu P; Muscari A; Puddu GM; Cravero E; Giannoni C; Zoli M
    Acta Cardiol; 2009 Apr; 64(2):157-65. PubMed ID: 19476106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets and their chemokines in atherosclerosis-clinical applications.
    von Hundelshausen P; Schmitt MM
    Front Physiol; 2014; 5():294. PubMed ID: 25152735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet function in ischemic heart disease.
    Picker SM
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):166-74. PubMed ID: 23107874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
    Schäfer A; Bauersachs J
    Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis.
    Fuentes Q E; Fuentes Q F; Andrés V; Pello OM; Font de Mora J; Palomo G I
    Platelets; 2013; 24(4):255-62. PubMed ID: 22671308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps.
    Marx C; Novotny J; Salbeck D; Zellner KR; Nicolai L; Pekayvaz K; Kilani B; Stockhausen S; Bürgener N; Kupka D; Stocker TJ; Weckbach LT; Pircher J; Moser M; Joner M; Desmet W; Adriaenssens T; Neumann FJ; Gerschlick AH; Ten Berg JM; Lorenz M; Stark K
    Blood; 2019 Nov; 134(21):1859-1872. PubMed ID: 31481482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective role of Nck1 in atherogenic inflammation and plaque formation.
    Alfaidi M; Acosta CH; Wang D; Traylor JG; Orr AW
    J Clin Invest; 2020 Aug; 130(8):4331-4347. PubMed ID: 32427580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of platelets in haemostasis, thrombosis, immune defense and inflammation].
    Jurk K; Kehrel BE
    Dtsch Med Wochenschr; 2008 May; 133(21):1130-5. PubMed ID: 18478507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.
    Diehl P; Nienaber F; Zaldivia MTK; Stamm J; Siegel PM; Mellett NA; Wessinger M; Wang X; McFadyen JD; Bassler N; Puetz G; Htun NM; Braig D; Habersberger J; Helbing T; Eisenhardt SU; Fuller M; Bode C; Meikle PJ; Chen YC; Peter K
    Thromb Haemost; 2019 Aug; 119(8):1295-1310. PubMed ID: 31378855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
    Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
    Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Involvement of Toll-like Receptor-2 in Arterial Thrombus Formation.
    Reinhardt C
    Hamostaseologie; 2018 Nov; 38(4):223-228. PubMed ID: 30261531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets in thrombosis and hemostasis: old topic with new mechanisms.
    Wang Y; Andrews M; Yang Y; Lang S; Jin JW; Cameron-Vendrig A; Zhu G; Reheman A; Ni H
    Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):126-32. PubMed ID: 23030445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets and von Willebrand factor in atherogenesis.
    Wu MD; Atkinson TM; Lindner JR
    Blood; 2017 Mar; 129(11):1415-1419. PubMed ID: 28174163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune receptors in platelets and platelet-leukocyte interactions.
    Dib PRB; Quirino-Teixeira AC; Merij LB; Pinheiro MBM; Rozini SV; Andrade FB; Hottz ED
    J Leukoc Biol; 2020 Oct; 108(4):1157-1182. PubMed ID: 32779243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathogenesis of atherosclerosis: atherogenesis and inflammation.
    Munro JM; Cotran RS
    Lab Invest; 1988 Mar; 58(3):249-61. PubMed ID: 3279259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.